Reported Earlier, Annexon Presents Phase 2 Data On ANX007 In Dry AMD Patients With Less Advanced GA At AAO 2024
Benzinga Newsdesk 2 years ago
News
Enhanced protection of vision with ANX007 treatment in healthier eyes Greater preservation of EZ in the central fovea by ANX007 in patients with less advanced GA Pivotal Phase 3 ARCHER II Data Expected Second Half
- Enhanced protection of vision with ANX007 treatment in healthier eyes
- Greater preservation of EZ in the central fovea by ANX007 in patients with less advanced GA
- Pivotal Phase 3 ARCHER II Data Expected Second Half 2026